Most of the research and clinical use of NAC has been in lung disease, both for its antioxidant effects and its mucus-thinning action
Compared to my usual glass-skin routine staples, this holds its own
ROS production and associated inflammation are closely related to aging and numerous chronic diseases as diabetes, cardiovascular and respiratory diseases, known risk factors for developing severe illness and death in patients with SARS-CoV-2 and COVID-19 disease
But with with its amazing benefits come some potential concerns around its safety and potential side effects
3 In the REIMAGINE 1 trial, the most commonly reported adverse events (AEs) were gastrointestinal (GI)-related, occurring in 33/62 (53%) participants in the CagriSema 2.4 mg/2.4 mg group, 28/63 (44%) participants in the CagriSema 1 mg/1 mg group, and 13/64 (20%) participants in the placebo group